Sponsorship

Bridging the gap between industry and HHT treatment

Where industry and HHT treatment meet. 2017 is Cure HHT’s Year of Possibilities. What better way to discover new treatment devices, targeted drug therapies, genetic diagnostics then by collaborating with global opinion leaders who specialize in HHT. The possibilities are limitless and they start with you!

Sponsorship Opportunities Sponsorship Agreement

Sponsors and Exhibitors

A special thanks to our sponsors for helping to bridge the gap.

curehht

Conference Host

Welcome to the 12th HHT International Scientific Conference. Cure HHT is excited to host this critically important event. We are grateful for the dedicated and internationally renowned HHT community of clinicians and scientists that share our mission to engage the scientific and medical community, collaborate with multidisciplinary HHT Centers worldwide and educate our community of patients, physicians, academic institutions, professional associations and corporate partners about this disease so that 1.4 million people worldwide affected by HHT are empowered to live a normal life. Visit www.curehht.org

GOLD SPONSOR

actelion_logo-black

Actelion Pharmaceuticals Ltd is a biopharmaceutical company that focuses on the development and commercialization of innovative treatments. Actelion specializes in orphan diseases and are the leaders in PAH therapy.  With a culture that fosters innovation, science, and care for patients, Actelion’s discoveries bring profound value to society and satisfy unmet medical needs.  Learn more at www.actelion.com.

SILVER SPONSOR

logo-medtronic

Medtronic is a global healthcare solutions company committed to improving the lives of people through our medical technologies, services, and solutions. By joining together with Covidien, we can accelerate and advance our ability to create meaningful innovations so hospitals, health systems, and healthcare providers can deliver the best care possible to patients around the world. Learn more at www.medtronic.com 

BRONZE SPONSOR

logo_balt

BALT, a key leader in interventional neuroradiology. Globally supporting healthcare professionals with integrity for over 40 years by designing cutting-edge technology and manufacturing reliable and high quality products. Learn more at www.balt.fr

logo-cook-medical

A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biological grafts and cell therapies across more than 16000 products serving more than 40 medical specialties. Learn more at www.cookmedical.com

logo-recursion

 

Recursion Pharmaceuticals is a drug discovery company combining experimental biology with artificial intelligence and bioinformatics to discover new therapeutic opportunities for rare genetic diseases or any disease that can be modeled in cells. Founded in 2013, Recursion is making strides towards the ambitious goal of treating 100 diseases in 10 years. Learn more at www.recursionpharma.com/.

EXHIBITOR

logo-impact-genetics

Impact Genetics, previously HHT Solutions, provides high quality HHT genetic diagnostics. With its leading edge technology, focused gene and disease-specific knowledge, and Dr. Michelle Letarte’s expert – scientific oversight, Impact Genetics is able to offer state of the art HHT testing. Impact Genetics testing is available for United States patients through LabCorp. Learn more at www.impactgenetics.com

YOUNG INVESTIGATOR SCHOLARSHIP FUND

logo-burroughs-wellcome-fund

The Burroughs Wellcome Fund is an independent private foundation located in Research Triangle Park, N.C.  Its mission is to advance the basic biomedical sciences by supporting research and education in the U.S. and Canada.  Current grant deadlines are available on the BWF homepage, www.bwfund.org

Stephen and MiAnne Liu are proud supporters of HHT research in honor of their daughter, Dorothy.

logo-recursion

 

Recursion Pharmaceuticals is a drug discovery company combining experimental biology with artificial intelligence and bioinformatics to discover new therapeutic opportunities for rare genetic diseases or any disease that can be modeled in cells. Founded in 2013, Recursion is making strides towards the ambitious goal of treating 100 diseases in 10 years. Learn more at www.recursionpharma.com/.

logo-tracon

Our goal is to be a leader in the development of targeted therapies for patients with cancer and other diseases of high unmet need. TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics. Learn more at www.traconpharma.com